This study will assess the safety and efficacy of ixekizumab (LY2439821) compared to placebo in participants with active AS.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01870284?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
This study will assess the safety and efficacy of ixekizumab (LY2439821) compared to placebo in participants with active AS.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01870284?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
Improving orthopaedic care, education and research using Internet technologies